84 related articles for article (PubMed ID: 2577412)
1. Peritoneal equilibration curve for beta-2-microglobulin (B2M) in CAPD patients.
Catizone L; Cocchi R; Gagliardini R; Rovinetti C; Fusaroli M; Zucchelli P
Adv Perit Dial; 1989; 5():200-3. PubMed ID: 2577412
[TBL] [Abstract][Full Text] [Related]
2. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
3. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
Nishina M; Endoh M; Suzuki D; Tanabe R; Endoh H; Hirahara I; Sakai H
Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
[TBL] [Abstract][Full Text] [Related]
4. Transport of peritoneal membrane assessed before and after the start of peritoneal dialysis.
La Milia V; Limardo M; Cavalli A; Crepaldi M; Locatelli F
Nephrol Dial Transplant; 2009 Sep; 24(9):2894-8. PubMed ID: 19349295
[TBL] [Abstract][Full Text] [Related]
5. Outcome for continuous ambulatory peritoneal dialysis patients is not predicted by peritoneal permeability characteristics.
Passadakis PS; Thodis ED; Panagoutsos SA; Selisiou CA; Pitta EM; Vargemezis VA
Adv Perit Dial; 2000; 16():2-6. PubMed ID: 11045251
[TBL] [Abstract][Full Text] [Related]
6. Short peritoneal equilibration test: impact of preceding dwell time.
Twardowski ZJ; Prowant BF; Moore HL; Lou LC; White E; Farris K
Adv Perit Dial; 2003; 19():53-8. PubMed ID: 14763034
[TBL] [Abstract][Full Text] [Related]
7. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
[TBL] [Abstract][Full Text] [Related]
8. Dialysate to plasma solute concentration (D/P) versus peritoneal transport parameters in CAPD.
Heimbürger O; Waniewski J; Werynski A; Park MS; Lindholm B
Nephrol Dial Transplant; 1994; 9(1):47-59. PubMed ID: 8177476
[TBL] [Abstract][Full Text] [Related]
9. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?
Douma CE; de Waart DR; Struijk DG; Krediet RT
Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660
[TBL] [Abstract][Full Text] [Related]
10. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 1999; 15():60-4. PubMed ID: 10682073
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of body size indices, residual renal function, and peritoneal transport characteristics in continuous ambulatory peritoneal dialysis.
Twardowski ZJ; Moore HL; Prowant BF; Satalowich R
Adv Perit Dial; 2009; 25():155-64. PubMed ID: 19886338
[TBL] [Abstract][Full Text] [Related]
12. Bacterial peritonitis and beta-2 microglobulin (B2M) production by peritoneal macrophages (PM0) in CAPD patients.
Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Canepa M; Zanin T; Cantaluppi A; Salit M
Adv Perit Dial; 1990; 6():106-9. PubMed ID: 1982784
[TBL] [Abstract][Full Text] [Related]
13. Serum B2 microglobulin (B2M) in CAPD.
Duranti E; Sasdelli M
Adv Perit Dial; 1989; 5():195-9. PubMed ID: 2577410
[TBL] [Abstract][Full Text] [Related]
14. The effect of glucose polymers on water removal and protein clearances during CAPD.
Imholz AL; Brown CB; Koomen GC; Arisz L; Krediet RT
Adv Perit Dial; 1993; 9():25-30. PubMed ID: 7692975
[TBL] [Abstract][Full Text] [Related]
15. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
[TBL] [Abstract][Full Text] [Related]
16. Continuous ambulatory peritoneal dialysis with a high flux membrane. A preliminary report.
Nolph KD; Moore HL; Prowant B; Twardowski ZJ; Khanna R; Gamboa S; Keshaviah P
ASAIO J; 1993; 39(3):M566-8. PubMed ID: 8268600
[TBL] [Abstract][Full Text] [Related]
17. Changes in peritoneal membrane transport rates in patients on long term CAPD.
Blake PG; Abraham G; Sombolos K; Izatt S; Weissgarten J; Ayiomamitis A; Oreopoulos DG
Adv Perit Dial; 1989; 5():3-7. PubMed ID: 2577421
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
19. [Serum beta 2-microglobulin concentration and its removal in patients treated with continuous ambulatory peritoneal dialysis].
Kubo H; Kawaguchi Y; Aizawa S; Morita T; Nakayama M; Wakabayashi Y; Watanabe S; Ogawa A; Sakai O
Nihon Jinzo Gakkai Shi; 1990 Apr; 32(4):419-26. PubMed ID: 2198365
[TBL] [Abstract][Full Text] [Related]
20. Discrepancy between solute transport rate and drain volume in CAPD patients with ascites.
Yoon SN; Yang CW; Lee SH; Kim YS; Choi EJ; Chang YS; Bang BK
Adv Perit Dial; 1996; 12():39-42. PubMed ID: 8865869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
